Prevalence of RDB, RSa, Hinc and Xmn polymorphisms and HBBS۱۱D haplotypes in patients with thalassemia minor

  • سال انتشار: 1401
  • محل انتشار: مجله تحقیقات سلولی، مولکولی و زیست پزشکی، دوره: 2، شماره: 3
  • کد COI اختصاصی: JR_CMBR-2-3_004
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 200
دانلود فایل این مقاله

نویسندگان

Seyyedeh Irankhah

Department of Genetics, Ahar Branch, Islamic Azad University, Ahar, Tabriz, Iran

Saied Hoseini-Asl

Unit of Genomics Research, Digestive Diseases Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

Mehdi Valizadeh

Unit of Genomics Research, Digestive Diseases Research Center, Ardabil University of Medical Sciences, Ardabil, Iran

Firouz Amani

Department of community medicine, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran

چکیده

Background: Beta-thalassemia is one of the most common genetic diseases with autosomal recessive inherited patterns in the world and is one of the most common diseases in Iran that exists in all age and sex groups. Determining gene mutations in this disease can be effective in controlling and treating the disease. The present study determined the frequency of polymorphisms of Hinc, RSaI, RDB, and Xmn in patients with beta-thalassemia minor in Ardabil province. Methods: ۵۳ beta-thalassemia patients referred to the genetic department of Imam Khomeini Hospital were studied. Blood samples were taken to determine the type of gene mutation. PCR samples were genetically evaluated to determine genetic mutations using RDB-Sequence-RFLP-Haplotype methods. Results: A total of ۵۳ samples were examined, of which ۵۶.۶% were male and the rest were female. The most positive cases in the first and second ranks were related to XmnI and AvaII enzymes with ۷۳.۵% and ۶۰.۳%, respectively. The most common mutation extracted in the studied samples with ۱۴ cases (۲۶.۴%) was IVS۲.۱. Among the most common mutations extracted by the RDB method was related to IVS ۱.۲ with ۲۶.۴%. Conclusions: The results of the present study showed that the distribution of genetic mutations in the studied samples can be different from other places. Also, by performing targeted genetic counseling, it is possible to control and prevent the disease in the future.

کلیدواژه ها

Beta-thalassemia, RDB, Mutation, Ardabil, Gene

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.